Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProMPT-2
ISRCTN15255199Phase 2Completed
- Sponsor
- University of Bristol
- Start
- Aug 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of propofol in myocardial ischemia-reperfusion injury, sponsored by University of Bristol. Primary endpoint: Myocardial injury. Started Aug 2018; status: completed.
02
Drugs
propofol
03
Conditions
myocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on ISRCTN15255199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15255199.